Can Spravato Be Taken at Home?

Can Spravato Be Taken at Home? Understanding the Safety Guidelines

Many patients seeking relief from treatment-resistant depression (TRD) wonder if Spravato® (esketamine) can be self-administered at home like traditional nasal sprays. The short answer is no. Due to strict FDA safety regulations under the REMS (Risk Evaluation and Mitigation Strategy) program, Spravato must be administered in a certified healthcare setting.

Why In-Clinic Supervision is Required: Unlike standard antidepressants, Spravato can cause immediate, temporary side effects that require professional monitoring. These include:

• Dissociation: A temporary feeling of being detached from your body or reality.

• Sedation: Significant drowsiness or reduced alertness.

• Blood Pressure Spikes: A temporary increase in blood pressure typically occurs shortly after administration.

What to Expect During Your Appointment: At Lyfe Unit, we ensure your treatment is safe and comfortable. During a typical session:

1. Supervised Administration: You will self-administer the nasal spray under the direct observation of a healthcare provider.

2. Observation Period: You will remain in a relaxing environment for at least two hours while our medical team monitors your vitals and well-being.

3. Post-Treatment Safety: Because of the sedative effects, you cannot drive or operate machinery until the following day. You must arrange for a ride home from the clinic.

While the “at-home” convenience isn’t available for Spravato, the clinical setting provides the highest level of safety and support for those managing severe depression.